Epobis
guinea pig
The Dose Guy’s verdictOct 27, 20262 sources
Pass on epobis for now. It is a clever idea, a piece of EPO that protects tissue without thickening your blood, but every result it has is from a dish or a rat, and nobody has ever given it to a person. ARA-290 does the same job from the same parent molecule and has actual human trials behind it. If tissue protection or nerve pain is what drew you here, look there instead.
What it is
Erythropoietin, EPO, is the hormone that tells your bone marrow to make red blood cells, and it also protects nerves and other tissue from injury. The trouble is the first job: run real EPO for protection and your blood thickens. Epobis is a short peptide designed from the crystal structure of EPO bound to its receptor, built as several copies of one chain on a branching core, meant to keep the protective signal and drop the red-cell one.
That is exactly the pitch of ARA-290, which also comes from EPO and also skips the blood effect. The difference is the paperwork: ARA-290 went into people with neuropathic pain, and epobis never left the lab. Its newest paper is not even about healing; it has epobis sharpening dopamine agonists like cabergoline against pituitary tumor cells in culture.
What the research shows
The whole base is cells and rats, and it is small. What it holds:
Realistic protocols
There is no protocol to give you. No human has a published dose, and the community barely runs this one, so there is not even settled forum lore worth repeating, and I won’t invent a number. If you want the EPO-derived tissue-protection idea in your body, ARA-290 is the version with human dosing to copy. If you run epobis anyway, keep the dose small and the run brief, write down what you take and what you feel, and get a COA on the vial because almost nobody makes it.
Side effects
No human has reported a side effect, because no human has been studied. What deserves respect:
